Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Makow Podhalanski

12 clinical trials in Makow Podhalanski, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Makow Podhalanski at a glance
12
clinical trials
  • Recruiting now0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Makow Podhalanski

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Allergy Therapeutics (UK) Limited

Asthma

Not yet recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Asthma

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Asthma

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Axatilimab
  • Sponsor:Syndax Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Betula Pollen Extract
  • Sponsor:Stallergenes

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Makow Podhalanski

What the registry says about research in the country

01 Respiratory Disorders

Innovative research focusing on moderate to severe asthma management, evaluating new formulations and delivery systems for improved patient outcomes.

  • Asthma Control Studies
  • Inhaler Technology Assessment
  • Exacerbation Prevention

Multiple trials are exploring novel therapeutic approaches for patients uncontrolled on standard maintenance therapy.

02 Allergic Conditions

Comprehensive studies addressing allergic rhinoconjunctivitis and seasonal allergies, with particular focus on birch pollen-induced conditions.

  • Immunotherapy Trials
  • Pediatric Allergy Studies
  • Seasonal Allergy Management

Research aims to validate new treatment options for both children and adults affected by seasonal allergies.

03 Pulmonary Diseases

Groundbreaking research investigating treatments for idiopathic pulmonary fibrosis and specialized studies on eosinophilic conditions.

  • Lung Function Assessment
  • Novel Therapeutic Approaches
  • Long-term Disease Management

Clinical trials focus on improving lung function and quality of life for patients with chronic respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.